Two U.S. luxury houses and the FTC are set to battle in court to reach a final decision that will change the market.

The devil in the Harris and Trump economic plans is in the details. Both candidates need to do a better job explaining how ...

The Federal Trade Commission (FTC) filed a lawsuit Friday against three major prescription drug benefit managers (PBMs) and ...

Mastercard (NYSE: MA) stock price has done well since going public in 2006 when it raised $2.4 billion. It has jumped by ...

U.S. Federal Trade Commission Chair Lina Khan on Friday welcomed that companies are weighing antitrust considerations early ...

Vice President Kamala Harris campaigned on reproductive rights this afternoon in Atlanta before heading to Madison, Wisconsin ...

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

The Federal Trade Commission said that it is suing the three major US pharmacy benefit managers over their role in the ...

Although a court decision could still be weeks away, Wall Street analysts and investors are predicting the deal with Albertsons won’t get approved.

Also: How brands are using community rewards platform TYB, macroeconomic news in a nutshell, and more data-driven news.

A House committee advanced sweeping online protections for kids Wednesday, but many lawmakers did so begrudgingly.